Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC 157 Benefits: What It Does for Gut, Joints, Muscle, and Recovery Theres a lot of confusion about the difference between BPC 157 arginate and acetate forms, so lets clear that up. The key distinction comes down to stability in the gut. This only applies to oral Is BPC 157 Banned? Oral vs. Injectable Forms Explained BPC 157 and Healing Peptides: Hype or Hope? A Doctor's Comprehensive Perspective MSK Doctor Zaid Matti